DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $9,022,000 | -43.1% | 27,422 | -47.3% | 0.56% | -46.3% |
| Q3 2021 | $15,846,000 | -0.4% | 52,051 | -2.7% | 1.04% | +6.1% |
| Q2 2021 | $15,912,000 | -17.5% | 53,486 | -37.6% | 0.98% | -16.2% |
| Q1 2021 | $19,297,000 | -3.7% | 85,736 | -4.9% | 1.17% | -6.7% |
| Q4 2020 | $20,035,000 | +0.2% | 90,191 | -2.9% | 1.26% | -8.7% |
| Q3 2020 | $20,004,000 | +20.5% | 92,897 | -3.5% | 1.38% | +14.6% |
| Q2 2020 | $16,595,000 | +22.0% | 96,271 | -2.1% | 1.20% | +5.4% |
| Q1 2020 | $13,604,000 | -14.1% | 98,287 | -4.7% | 1.14% | +11.0% |
| Q4 2019 | $15,831,000 | +3.8% | 103,149 | -2.3% | 1.03% | -5.1% |
| Q3 2019 | $15,250,000 | -13.9% | 105,587 | -14.8% | 1.08% | -12.8% |
| Q2 2019 | $17,721,000 | +6.1% | 123,995 | -2.0% | 1.24% | +4.5% |
| Q1 2019 | $16,704,000 | +27.1% | 126,528 | -0.7% | 1.19% | +24.7% |
| Q4 2018 | $13,138,000 | +0.8% | 127,404 | -2.1% | 0.95% | +20.3% |
| Q3 2018 | $13,029,000 | +2.8% | 130,176 | +1.3% | 0.79% | -1.5% |
| Q2 2018 | $12,676,000 | -5.2% | 128,451 | -5.9% | 0.80% | -1.0% |
| Q1 2018 | $13,371,000 | +3.7% | 136,561 | -1.7% | 0.81% | +10.0% |
| Q4 2017 | $12,897,000 | +2.2% | 138,951 | -5.5% | 0.74% | -0.5% |
| Q3 2017 | $12,619,000 | -2.2% | 147,112 | -4.2% | 0.74% | +11.6% |
| Q2 2017 | $12,905,000 | -7.2% | 153,575 | -5.5% | 0.66% | -5.4% |
| Q1 2017 | $13,901,000 | +6.1% | 162,532 | -3.4% | 0.70% | +2.2% |
| Q4 2016 | $13,100,000 | -6.3% | 168,292 | -5.6% | 0.69% | -0.7% |
| Q3 2016 | $13,981,000 | -25.0% | 178,357 | -3.4% | 0.69% | -24.3% |
| Q2 2016 | $18,646,000 | -1.4% | 184,614 | -7.4% | 0.92% | -0.7% |
| Q1 2016 | $18,910,000 | -3.1% | 199,348 | -5.1% | 0.92% | -2.4% |
| Q4 2015 | $19,507,000 | +5.6% | 210,024 | -3.1% | 0.94% | +0.4% |
| Q3 2015 | $18,477,000 | -5.0% | 216,837 | -4.6% | 0.94% | +6.6% |
| Q2 2015 | $19,458,000 | -8.0% | 227,338 | -8.7% | 0.88% | +2.7% |
| Q1 2015 | $21,147,000 | -1.9% | 249,077 | -1.0% | 0.86% | -5.6% |
| Q4 2014 | $21,567,000 | +11.0% | 251,631 | -1.6% | 0.91% | +8.3% |
| Q3 2014 | $19,427,000 | -5.1% | 255,686 | -1.6% | 0.84% | -2.4% |
| Q2 2014 | $20,465,000 | +3.8% | 259,943 | -1.2% | 0.86% | +0.6% |
| Q1 2014 | $19,724,000 | -10.4% | 262,992 | -7.7% | 0.86% | -9.7% |
| Q4 2013 | $22,005,000 | +10.5% | 285,035 | -0.8% | 0.95% | +1.0% |
| Q3 2013 | $19,912,000 | +3.8% | 287,250 | -7.4% | 0.94% | +7.2% |
| Q2 2013 | $19,183,000 | – | 310,304 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |